Oaktree Acquisition Corp. III Life Sciences (OACC) Current Assets (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences filings provide 3 years of Current Assets readings, the most recent being $1.4 million for Q1 2026.

  • Quarterly Current Assets fell 4.47% to $1.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Mar 2026, down 4.47% year-over-year, with the annual reading at $1.5 million for FY2025, 0.65% down from the prior year.
  • Current Assets hit $1.4 million in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, down from $1.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $1.6 million in Q2 2025 and bottomed at $1.4 million in Q1 2026.
  • Average Current Assets over 3 years is $1.5 million, with a median of $1.5 million recorded in 2025.
  • The largest annual shift saw Current Assets fell 0.65% in 2025 before it decreased 4.47% in 2026.
  • Oaktree Acquisition Corp. III Life Sciences' Current Assets stood at $1.6 million in 2024, then decreased by 0.65% to $1.5 million in 2025, then dropped by 8.53% to $1.4 million in 2026.
  • Per Business Quant, the three most recent readings for OACC's Current Assets are $1.4 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025).